Alkhars Abdulwahab Ahmed A, Alkadi Mohammed A, Alwabari Hussain M, Mandong Jagshak, Almakinah Zahraa Y
Internal Medicine, King Fahad Hospital Hofuf, Hofuf, SAU.
Cureus. 2024 Dec 24;16(12):e76299. doi: 10.7759/cureus.76299. eCollection 2024 Dec.
Sickle cell anemia (SCA) is one of the known hemoglobinopathies that result in red blood cell (RBC) destruction, among other complications. There are factors that make SCA an environment for autoimmune disease (AID). They include chronic inflammation, immune-mediated processes involved in SCA complications, and susceptibility to infections. Furthermore, immune thrombocytopenia (ITP) is a complex disorder characterized by immune imbalance that results in platelet destruction. We report a case of a 20-year-old patient with SCA presenting with a vaso-occlusive crisis (VOC) and unexplained thrombocytopenia. After ruling out secondary causes of the latter condition, the patient was challenged with steroid therapy. Interestingly, he showed a dramatic response in platelet count. This report emphasizes the potential role of SCA in the development of ITP and encourages further studies to explore the underlying immunological mechanisms.
镰状细胞贫血(SCA)是一种已知的血红蛋白病,除其他并发症外,还会导致红细胞(RBC)破坏。有一些因素使SCA成为自身免疫性疾病(AID)的发病环境。这些因素包括慢性炎症、SCA并发症中涉及的免疫介导过程以及对感染的易感性。此外,免疫性血小板减少症(ITP)是一种复杂的疾病,其特征是免疫失衡导致血小板破坏。我们报告一例20岁SCA患者,出现血管闭塞性危机(VOC)和不明原因的血小板减少症。在排除后者的继发原因后,对该患者进行了类固醇治疗挑战。有趣的是,他的血小板计数出现了显著反应。本报告强调了SCA在ITP发生发展中的潜在作用,并鼓励进一步研究以探索潜在的免疫机制。